<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02801006</url>
  </required_header>
  <id_info>
    <org_study_id>JP-MKTG-201603</org_study_id>
    <nct_id>NCT02801006</nct_id>
  </id_info>
  <brief_title>The Clinical Study of Silicone Hydrogel Daily Disposable Stenfilcon A Toric Lens</brief_title>
  <official_title>The Clinical Study of Silicone Hydrogel Daily Disposable Stenfilcon A Toric Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the clinical performance of stenfilcon A toric lenses
      compared with etafilcon A toric lenses for astigmatism. If it is valuable, the clinical
      performance of stenfilcon A toric lens is also evaluated compared with habitual lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-sites, 50 subjects, randomized, open labeled, bilateral wear, dispensing
      study. Participants will be randomized to wear first lens pair for two weeks, and then
      crossover to second lens pair for two weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">October 31, 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort</measure>
    <time_frame>2 weeks</time_frame>
    <description>Wearing comfort (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0= extremely uncomfortable cannot wear at all, 10=very comfortable and feel no lens at all</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dryness</measure>
    <time_frame>2 weeks</time_frame>
    <description>Dryness (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=extremely dried and cannot wear lens, 10=feel no dryness at all</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clarity of Vision</measure>
    <time_frame>2 weeks</time_frame>
    <description>Clarity of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=blur vision and cannot see at all, 10=very clear with no blur vision at all</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stability of Vision</measure>
    <time_frame>2 weeks</time_frame>
    <description>Stability of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=unstable vision and cannot see at all, 10=always stable vision</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Handling</measure>
    <time_frame>2 weeks</time_frame>
    <description>Lens handling for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=cannot handle at all, 10=no problem at all</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Satisfaction</measure>
    <time_frame>2 weeks</time_frame>
    <description>Overall satisfaction for stenfilcon A and etafilcon A toric lens pair is assessed. scale 0-10, 0=extremely un-satisfy, 10=very satisfy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>stenfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be randomized to wear stenfilcon A lens pair for two weeks during the cross over study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>etafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be randomized to wear etafilcon A lens pair for two weeks during the cross over study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stenfilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>stenfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>etafilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        A person is eligible for inclusion in the study if he/she:

          -  Is between 18 years of age and 42 years of age.

          -  Soft contact lens wearers who are not required to have Presbyopic correction.

          -  Soft contact lens wearers without trouble.

          -  Soft contact lens wearers who have the correctable astigmatism by lenses used in this
             study in the both eyes.

          -  Has a prescribed SCL (Soft Contact Lens) power within the range of powers of the SCL
             for astigmatism which is used in this study.

          -  Can achieve a corrected visual acuity of 1.0 or better.

          -  Can read and understand the study information document, and sign the participation
             consent form.

          -  Can visit the clinic at designated examination visits.

          -  Has received periodical examinations at an eye clinic within the past two years.

        Exclusion Criteria:

        A person will be excluded from the study if he/she:

          -  Has a systemic disease that may affect the ocular health.

          -  Is pregnant or lactating.

          -  Has received a systemic or local medication that may affect this study.

          -  Has an infectious eye disease.

          -  Has eye and systemic active allergic diseases that interferes with SCL wear.

          -  Has an eye disease which is clinically judged to be severe such as corneal
             vascularization, limbal hyperemia, and corneal epithelium disorder

          -  Has a history of hard contact lens wear within 30 days.

          -  Is currently participating in another clinical research study.

          -  Has undergone refractive surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuji Kodama, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Kodama Eye Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kodama Eye Clinic</name>
      <address>
        <city>Terada</city>
        <state>Kyoto</state>
        <zip>610-0121</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dougenzaka Ioti Eye Clinic</name>
      <address>
        <city>Shibuya</city>
        <state>Tokyo-to</state>
        <zip>150-0043</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <results_first_submitted>November 8, 2017</results_first_submitted>
  <results_first_submitted_qc>November 8, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">December 12, 2017</results_first_posted>
  <disposition_first_submitted>October 5, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>October 17, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">October 19, 2017</disposition_first_posted>
  <last_update_submitted>December 11, 2017</last_update_submitted>
  <last_update_submitted_qc>December 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Stenfilcon A First, Then Etafilcon A</title>
          <description>Participants randomized to wear stenfilcon A toric lens pair for two weeks then etafilcon A toric lens pair in the cross over study.</description>
        </group>
        <group group_id="P2">
          <title>Etafilcon A First, Then Stenfilcon A</title>
          <description>Participants randomized to wear stenfilcon A toric lens pair for two weeks then etafilcon A toric lens pair in the cross over study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Lens 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Lens 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>Total participants enrolled</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="41"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort</title>
        <description>Wearing comfort (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0= extremely uncomfortable cannot wear at all, 10=very comfortable and feel no lens at all</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stenfilcon A</title>
            <description>Participants randomized to wear stenfilcon A toric lens pair (either first or second) for two weeks during the cross over study.
stenfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Etafilcon A Toric</title>
            <description>Participants randomized to wear etafilcon A lens pair (either first of second) for two weeks during the cross over study.
etafilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort</title>
          <description>Wearing comfort (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0= extremely uncomfortable cannot wear at all, 10=very comfortable and feel no lens at all</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="2.0"/>
                    <measurement group_id="O2" value="7.4" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dryness</title>
        <description>Dryness (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=extremely dried and cannot wear lens, 10=feel no dryness at all</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stenfilcon A</title>
            <description>Participants randomized to wear stenfilcon A toric lens pair (either first or second) for two weeks during the cross over study.
stenfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Etafilcon A</title>
            <description>Participants randomized to wear etafilcon A toric lens pair (either first or second) for two weeks during the cross over study.
etafilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Dryness</title>
          <description>Dryness (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=extremely dried and cannot wear lens, 10=feel no dryness at all</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" spread="2.0"/>
                    <measurement group_id="O2" value="7.4" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clarity of Vision</title>
        <description>Clarity of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=blur vision and cannot see at all, 10=very clear with no blur vision at all</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stenfilcon A</title>
            <description>Participants randomized to wear stenfilcon A toric lens pair (either first or second) for two weeks during the cross over study.
stenfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Etafilcon A</title>
            <description>Participants randomized to wear etafilcon A toric lens pair (either first or second) for two weeks during the cross over study.
etafilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Clarity of Vision</title>
          <description>Clarity of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=blur vision and cannot see at all, 10=very clear with no blur vision at all</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="1.9"/>
                    <measurement group_id="O2" value="7.8" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Stability of Vision</title>
        <description>Stability of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=unstable vision and cannot see at all, 10=always stable vision</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stenfilcon A</title>
            <description>Participants randomized to wear stenfilcon A toric lens pair (either first or second) for two weeks during the cross over study.
stenfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Etafilcon A</title>
            <description>Participants randomized to wear etafilcon A toric lens pair (either first of second) for two weeks during the cross over study.
etafilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Stability of Vision</title>
          <description>Stability of vision (throughout the day) for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=unstable vision and cannot see at all, 10=always stable vision</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="1.8"/>
                    <measurement group_id="O2" value="8.0" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Handling</title>
        <description>Lens handling for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=cannot handle at all, 10=no problem at all</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stenfilcon A</title>
            <description>Participants randomized to wear stenfilcon A toric lens pair (either first or second) for two weeks during the cross over study.
stenfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Etafilcon A</title>
            <description>Participants randomized to wear etafilcon A toric lens pair (either first of second) for two weeks during the cross over study.
etafilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Handling</title>
          <description>Lens handling for stenfilcon A and etafilcon A toric lens pair is assessed. Scale 0-10, 0=cannot handle at all, 10=no problem at all</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>At Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" spread="1.8"/>
                    <measurement group_id="O2" value="7.6" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At Removal</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" spread="2.9"/>
                    <measurement group_id="O2" value="8.9" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Satisfaction</title>
        <description>Overall satisfaction for stenfilcon A and etafilcon A toric lens pair is assessed. scale 0-10, 0=extremely un-satisfy, 10=very satisfy</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stenfilcon A</title>
            <description>Participants randomized to wear stenfilcon A toric lens pair (either first or second) for two weeks during the cross over study.
stenfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Etafilcon A</title>
            <description>Participants randomized to wear etafilcon A toric lens pair (either first of second) for two weeks during the cross over study.
etafilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Satisfaction</title>
          <description>Overall satisfaction for stenfilcon A and etafilcon A toric lens pair is assessed. scale 0-10, 0=extremely un-satisfy, 10=very satisfy</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="2.0"/>
                    <measurement group_id="O2" value="7.2" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 weeks for each round of lens wear.</time_frame>
      <desc>Adverse events were assessed for during the follow-up study visits.</desc>
      <group_list>
        <group group_id="E1">
          <title>Stenfilcon A</title>
          <description>Participants randomized to wear stenfilcon A lens pair either as first or second pair in this crossover study.</description>
        </group>
        <group group_id="E2">
          <title>Etafilcon A</title>
          <description>Participants randomized to wear etafilcon A lens pair either as first or second pair in this crossover study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jose Vega, O.D., MSc., FAAO</name_or_title>
      <organization>CooperVision</organization>
      <phone>9256213761</phone>
      <email>javega@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

